Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
A Virtual HIV Clinic Could Be the Precursor to Anonymous Online STD Testing

A new program being run in partnership with the University of Iowa Health Care is offering people at risk of HIV infection the option to seek PrEP online, via video conferencing. The program creates what is basically a virtual HIV clinic, an innovative way to get around the social stigmas associated with HIV.

Published
12 September 2017
From
Video Conferencing Daily
A Stocktake Review of DFID’s Work on HIV and AIDS

DFID’s overall funding for HIV is falling. Despite the UK’s substantial contribution to the Global Fund, massive cuts to DFID’s country office programmes focused on HIV have led to a decrease in funding from £416m in 2012 to £324 in 2015.

Published
12 September 2017
From
STOP AIDS
New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate

A new US model of the cost-effectiveness of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM), prepared by researchers at Emory University in

Published
12 September 2017
By
Gus Cairns
A Venezuelan woman had grown used to shortages. Then her HIV drugs ran out.

Doctors are struggling to cope with a surging HIV/AIDS crisis that experts fear could become the worst in Latin America in years. Caracas’s largest hospitals are now scrambling to cope with an influx of both newly infected and deteriorating HIV patients, their emaciated bodies evoking the distressing images that defined the virus in the 1980s.

Published
11 September 2017
From
Washington Post
Watch: USCA Plenary Halted by Trans Activists

The United States Conference on AIDS (USCA), celebrating thirty years of teaching practical skills to HIV service providers, found itself the target of old-school activism on Friday when transgender activists stopped the plenary program to voice their frustrations about being underrepresented by the organizations in attendance and by the conference itself.

Published
11 September 2017
From
My Fabulous Disease
J&J unit ends hepatitis C drug development in crowded market

Janssen Sciences Ireland UC, a unit of Johnson & Johnson, said it would discontinue further development of its hepatitis C research, citing increased availability of a number of effective hepatitis C therapies.

Published
11 September 2017
From
Reuters
Generic PrEP in France and Scotland challenges access across the UK

The issue of drug procurement and pricing is complex but it is difficult to see how different patents should apply within Europe, and especially not within the UK.

Published
08 September 2017
From
HIV i-Base
5 things you need to know to join the IMPACT trial

The PrEP IMPACT trial is a clinical trial in England and will operate differently to the ways you usually get sexual health services. You'll need to meet eligibility criteria to go on the trial, and you'll need to read and sign paperwork before you start. You'll also be asked to visit your trial clinic every 3 months for HIV and STI tests. The PrEP IMPACT trial starts in September 2017 – and there are 5 important sets of things you need to know if you’re thinking about joining the trial.

Published
07 September 2017
From
PrEPster
No new HIV infections among Kaiser PrEP users, but data shows missed opportunities

No new HIV infections have occurred among nearly 5000 people who started Truvada for pre-exposure prophylaxis (PrEP) in the Kaiser Permanente Northern California health system, according to a

Published
07 September 2017
By
Liz Highleyman
Advisory Council on the Misuse of Drugs issues stark warning on funding cuts

Funding cuts are the ‘single biggest threat’ to treatment recovery outcomes, according to the government’s own advisors, the ACMD. Maintaining funding levels for treatment is ‘essential’ for preventing drug-related deaths and crime, states Commissioning impact on drug treatment, which contains examples of funding reductions brought about by re-procurement or variations to existing contracts.

Published
07 September 2017
From
Drink & Drug News

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.